Los Angeles Convention Center
Los Angeles, CA
May 16-20, 2023

Dyne Therapeutics

Waltham,  MA 
United States

Dyne Therapeutics is building a leading muscle disease company dedicated to advancing life-transforming therapeutics for people living with genetically driven diseases. With its proprietary FORCE™ platform, Dyne is developing modern oligonucleotide therapeutics that are designed to overcome limitations in delivery to muscle tissue seen with other approaches. Dyne has a broad portfolio of programs for serious muscle diseases, including candidates for myotonic dystrophy type 1 (DM1), Duchenne muscular dystrophy (DMD) and facioscapulohumeral muscular dystrophy (FSHD).